Cevilc Tablet
Marketer
Mba Pharmaceuticals Pvt. Ltd.
Salt Composition
Imatinib mesylate (400mg)
Overview Cevilc Tablet
Cevilc tablets are indicated for various cancers, primarily blood cancers such as chronic myeloid leukemia and acute lymphocytic leukemia, as well as gastrointestinal stromal tumors. Its mechanism involves targeting proteins crucial for cancer cell proliferation and metastasis. Additionally, it's employed in treating dermatofibrosarcoma protuberans (a skin tumor) and aggressive systemic mastocytosis (a bone marrow disorder). Administer this medication with food, consistently at the same time daily for optimal efficacy. Treatment duration is individualized based on response and medical needs. Incorrect dosage or overuse can lead to severe adverse effects. Therapeutic benefits may not be immediately apparent (weeks or months), therefore, discontinue use only under physician guidance. Frequently reported side effects encompass edema, nausea, vomiting, muscle spasms, musculoskeletal discomfort, diarrhea, rash, fatigue, and abdominal pain. Report unexplained rapid weight increase to your physician. Regular blood count and liver function monitoring may be recommended. Avoid activities requiring alertness (e.g., driving) if dizziness or blurred vision occurs. Inform your healthcare provider of all other medications, as interactions are possible. This medication is contraindicated during pregnancy and lactation; effective contraception for both partners is essential throughout treatment.
Uses of Cevilc Tablet
Cancer Therapy
Major Benefits of Cevilc Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Cevilc Tablet with a meal.
Common Side effects of Cevilc Tablet:
- Edema (swelling)
- Nausea
- Vomiting
- Muscle cramp
- Musculoskeletal (bone, muscle or joint) pain
- Diarrhea
- Rash
- Fatigue
- Abdominal pain
- Bleeding
- Breathing problems
- Cough
- Weight gain
- Dry eye
- Dizziness
- Hemorrhage
How to use Cevilc Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cevilc Tablet should be administered with a meal.
How Cevilc Tablet works:
Cevilc tablets combat cancer by targeting the bcr-abl tyrosine kinase protein enzyme. This enzyme drives the uncontrolled growth of cancerous cells. The medication works by suppressing this growth and triggering programmed cell death (apoptosis) specifically in bcr-abl positive cancer cells, thus hindering or halting cancer progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption while taking Cevilc Tablet is undetermined. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Use of Cevilc Tablet is contraindicated during pregnancy due to established risk to the fetus. In exceptional life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Cevilc Tablet during breastfeeding is likely unsafe. Available evidence indicates potential drug transfer to breast milk, posing a risk to the infant. Nursing mothers must discontinue breastfeeding throughout treatment and for two weeks following cessation of Cevilc Tablet.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Cevilc Tablet.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when using Cevilc Tablet. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with significant hepatic impairment should exercise caution when using Cevilc Tablet; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Cevilc Tablet :
Omit any missed Cevilc Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Cevilc Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzanilide Derivative |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Category | Kinase inhibitors targeting tyrosine |



